Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 5 | 2025 | 852 | 1.510 |
Why?
|
| Nephritis, Interstitial | 2 | 2023 | 40 | 1.490 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 116 | 0.760 |
Why?
|
| Electrolytes | 1 | 2022 | 58 | 0.750 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 252 | 0.620 |
Why?
|
| Kidney Diseases | 1 | 2022 | 484 | 0.550 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 2 | 2025 | 19 | 0.410 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 1420 | 0.410 |
Why?
|
| Ceramides | 1 | 2013 | 46 | 0.400 |
Why?
|
| Agrochemicals | 2 | 2023 | 13 | 0.390 |
Why?
|
| Reperfusion Injury | 2 | 2025 | 109 | 0.380 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 91 | 0.370 |
Why?
|
| Kidney Tubules | 2 | 2025 | 77 | 0.270 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2026 | 53 | 0.240 |
Why?
|
| Acute Kidney Injury | 2 | 2025 | 690 | 0.230 |
Why?
|
| Kidney | 2 | 2023 | 1303 | 0.230 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2025 | 146 | 0.220 |
Why?
|
| Hyperinsulinism | 1 | 2024 | 58 | 0.200 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2024 | 78 | 0.200 |
Why?
|
| Mice | 8 | 2025 | 18394 | 0.190 |
Why?
|
| Paraquat | 1 | 2022 | 15 | 0.190 |
Why?
|
| Cations | 1 | 2022 | 37 | 0.190 |
Why?
|
| Protein Sorting Signals | 1 | 2022 | 41 | 0.180 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2022 | 93 | 0.180 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 126 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2026 | 621 | 0.170 |
Why?
|
| Peritoneal Dialysis | 1 | 2023 | 133 | 0.170 |
Why?
|
| Sirtuin 3 | 1 | 2021 | 31 | 0.170 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 32 | 0.160 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2020 | 25 | 0.160 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 475 | 0.160 |
Why?
|
| Animals | 8 | 2025 | 34262 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1249 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4733 | 0.140 |
Why?
|
| Coronary Angiography | 1 | 2020 | 457 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 518 | 0.130 |
Why?
|
| Mitochondria | 3 | 2022 | 766 | 0.130 |
Why?
|
| Renal Dialysis | 1 | 2024 | 953 | 0.120 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 199 | 0.120 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 520 | 0.120 |
Why?
|
| Virulence Factors | 1 | 2017 | 181 | 0.120 |
Why?
|
| Streptococcus pneumoniae | 1 | 2017 | 389 | 0.110 |
Why?
|
| Humans | 9 | 2026 | 132041 | 0.100 |
Why?
|
| Sphingosine | 1 | 2013 | 23 | 0.100 |
Why?
|
| DNA Fragmentation | 1 | 2013 | 56 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3851 | 0.100 |
Why?
|
| Sphingolipids | 1 | 2013 | 35 | 0.100 |
Why?
|
| Culture Media | 1 | 2013 | 175 | 0.100 |
Why?
|
| Male | 6 | 2025 | 65425 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 943 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 56 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 2657 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1175 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2013 | 379 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2011 | 106 | 0.080 |
Why?
|
| Female | 5 | 2024 | 71380 | 0.080 |
Why?
|
| Autophagy | 1 | 2013 | 424 | 0.080 |
Why?
|
| Risk Factors | 1 | 2023 | 11020 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2025 | 3864 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2011 | 683 | 0.060 |
Why?
|
| Child | 2 | 2023 | 26361 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3703 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17748 | 0.060 |
Why?
|
| High-Throughput Screening Assays | 1 | 2026 | 117 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 1002 | 0.060 |
Why?
|
| Crystallography, X-Ray | 1 | 2026 | 365 | 0.060 |
Why?
|
| Epithelium | 1 | 2025 | 344 | 0.060 |
Why?
|
| Small Molecule Libraries | 1 | 2026 | 135 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2026 | 555 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2024 | 82 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1811 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2025 | 831 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2026 | 1062 | 0.050 |
Why?
|
| Adenosine Monophosphate | 1 | 2023 | 49 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2024 | 239 | 0.050 |
Why?
|
| Alanine | 1 | 2023 | 162 | 0.050 |
Why?
|
| Leucine | 1 | 2022 | 261 | 0.040 |
Why?
|
| Superoxides | 1 | 2021 | 129 | 0.040 |
Why?
|
| Fibrosis | 1 | 2022 | 421 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2022 | 348 | 0.040 |
Why?
|
| Podocytes | 1 | 2020 | 76 | 0.040 |
Why?
|
| Disease Progression | 1 | 2025 | 2229 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2022 | 810 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 338 | 0.040 |
Why?
|
| Estradiol | 1 | 2021 | 482 | 0.040 |
Why?
|
| DNA | 1 | 2024 | 1440 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2025 | 4696 | 0.030 |
Why?
|
| Insulin | 1 | 2022 | 1152 | 0.030 |
Why?
|
| Catalysis | 1 | 2017 | 136 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 678 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2017 | 194 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1237 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2020 | 519 | 0.030 |
Why?
|
| Protein Domains | 1 | 2017 | 248 | 0.030 |
Why?
|
| Critical Illness | 1 | 2020 | 616 | 0.030 |
Why?
|
| Testosterone | 1 | 2021 | 604 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2364 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 984 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2011 | 75 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 609 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2020 | 3718 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3422 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 345 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 234 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4691 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 482 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2020 | 3133 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 2783 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 31747 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 21288 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 28946 | 0.010 |
Why?
|